期刊文献+

富含亮氨酸蛋白LRP130抗体在恶性肿瘤中的表达和临床意义 被引量:2

Expressions and clinical significance of LRPPRC in cancer
下载PDF
导出
摘要 目的:探讨富含亮氨酸蛋白LRP130抗体(LRPPRC)在胃癌、宫颈癌和前列腺癌的表达和临床意义。方法:应用免疫组化法检测120例胃癌、80例宫颈癌和198例前列腺癌组织中LRPPRC的表达;分析LRPPRC的表达和临床病理学参数的关系。结果:胃癌和正常胃组织LRPPRC的高表达率分别为71.7%(86/120)和21.7%(13/60),二者差异有统计学意义(P<0.001);宫颈癌和正常宫颈组织LRPPRC的高表达率分别为76.3%(61/80)和27.5%(11/40),二者差异有统计学意义(P<0.001);前列腺癌和前列腺增生组织LRPPRC的高表达率分别为61.6%(122/198)和18.0%(18/100),二者差异有统计学意义(P<0.001)。LRPPRC的高表达与前列腺癌患者的Gleason评分、血清PSA水平、雄激素阻断治疗后PSA下降水平和转移部位的数量相比呈显著正相关(P<0.05)。结论:恶性肿瘤组织LRPPRC表达增高;晚期前列腺癌LRPPRC的高表达预示恶性程度高和多发转移。 Objective: To investigate the expressions and clinical significance of LRPPRC in cancer. Methods: Immunohistochemistry was performed to analyze the LRPPRC expression in 120 of gatric cancer tissues? 80 of cervi-cal cancer tissues and 198 of prostate cancer tissues. The associations between LRPPRC and clinicopathological pa-rameters were analyzed. Results : Gastric cancer and normal gastric tissues highly expressed LRPPRC in 71. 7% (86/120) and 21. 7% (13/60) of patients, respectively (P〈0 .001 ) ; Cervical cancer and normal cervical tissues highly expressed LRPPRC in 76. 3% (61/80)and 27. 5% (11/40) of patients, respectively (P〈0 .001) ; Prostate cancer and prostate hyperplasia tissues highly expressed LRPPRC in 61. 6% (122/198) and 18. 0% (18/100) of pa-tients ,respectively (P〈0. 001). A significant associations between the expressions of LRPPRC and Gleason scores (P〈0. 001),serum PSA levels (P = 0. 002) , serum PSA levels after androgen deprivation therapy (P〈0. 022)and the numbers of metastasis position (P〈0. 001) were observed. Conclusion: There is higher LRPPRC expression in cancer tissues. The high expression of LRPPRC predicted high degree of malignant and more metastasis positions in late stage of prostate cancer patients.
出处 《陕西医学杂志》 CAS 2017年第5期674-676,共3页 Shaanxi Medical Journal
基金 陕西省延安市科技惠民计划项目(2015HM-11) 陕西省延安市常见恶性肿瘤基础与临床研究科技创新项目(2015CXTD-07)
关键词 胃肿瘤/病理学 前列腺肿瘤/病理学 抗体/代谢 @亮氨酸蛋白 Stomach neoplasms/pathology Prostatic neoplasms/pathology Antibodies/metabolism @LRPPRC
  • 相关文献

参考文献1

二级参考文献11

  • 1杨维良,张新晨,张东伟,马玉林,张浩民,赵志,张建国,梁春林.35岁以下胃癌患者380例临床分析[J].中华胃肠外科杂志,2004,7(5):357-359. 被引量:13
  • 2李华,路平,刘彩刚,司荣祥,关华鹤,徐惠绵.青年早期胃癌临床病理特征及预后因素探讨[J].中国普通外科杂志,2007,16(9):910-912. 被引量:13
  • 3Alici S,Kaya S,Izmirli M,et al.Analysis of survival factors in patients with advanced-stage gastric adenocarcinoma.[J].Med Sci Monit,2006,12(5):R221-R229.
  • 4Adachi Y,Ogawa Y,Sasaki Y,et al.A clinicopathologic study of gastric carcinoma with reference to age of patients.[J].J Clin Gastroenterol,1994,18(4):287-290.
  • 5Moriguchi S,Odaka T,Hayashi Y,et al.Death due to recurrence following curative resection of early gastric cancer depends on age of the patient.[J].Br J Cancer,1991,64(3):555-558.
  • 6Koea JB,Karpeh MS,Brennan MF.Gastric cancer in young patients:demographic,clinicopathological,and prognostic factors in 92patients.[J].Ann Surg Oncol,2000,7(5):346-351.
  • 7Shiraishi N,Inomata M,Osawa N,et al.Early and late recurrence after gastrectomy for gastric carcinoma.Univariate and multivariate analyses.[J].Cancer,2000,89(2):255-261.
  • 8Harrison J D,Jones J A,Ellis I O,et al.Oestrogen receptor D5antibody is an independent negative prognostic factor in gastric cancer.[J].Br J Surg,1991,78(3):334-336.
  • 9Saito H,Osaki T,Murakami D,et al.Macroscopic tumor size as a simple prognostic indicator in patients with gastric cancer.[J].Am J Surg,2006,192(3):296-300.
  • 10Kunisaki C,Makino H,Takagawa R,et al.Tumor diameter as a prognostic factor in patients with gastric cancer.[J].Ann Surg Oncol,2008,15(7):1959-1967.

共引文献7

同被引文献20

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部